beligas pharma

Boldenone Undecylenate

Mono-Femara 2.5 Mg 50 Tablets


Write to us for more information about this product.


SHIPPING COST : $35 (Delivery Time: 5-7 Days)

Payment Methods

Bitcoin, Zelle, Western Union, Money Gram, CashApp, Bank Transfer


Femara 2.5 mg 50 Tablets is a pharmaceutical product designed to provide effective treatment for hormone receptor-positive breast cancer in postmenopausal women. Each package contains 50 tablets, each tablet containing 2.5 milligrams of the active ingredient, letrozole.

Femara (generic name: letrozole) belongs to a class of medications called aromatase inhibitors. It works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens to estrogen. By blocking estrogen production, Femara helps reduce the growth and spread of estrogen-dependent breast tumors, thereby aiding in the treatment of breast cancer.

These tablets are prescribed by healthcare professionals specifically for postmenopausal women diagnosed with hormone receptor-positive breast cancer. The medication is usually taken once a day orally, with or without food, as directed by a healthcare provider.

Femara 2.5 mg 50 Tablets come in a convenient package that ensures easy storage and access. Each tablet is clearly labeled with the dosage strength, allowing for accurate and precise administration of the medication. It is essential to strictly follow the prescribed dosage and duration as advised by the healthcare professional.

Before using Femara, it is important to inform your doctor about any other medications, supplements, or medical conditions you may have, as certain medications and conditions may interact with Femara or affect its efficacy.

Like any medication, Femara may cause side effects, although not everyone experiences them. Common side effects may include hot flashes, joint pain, muscle pain, fatigue, headache, dizziness, and increased sweating. It is important to discuss any concerning or persistent side effects with your doctor.

Femara 2.5 mg 50 Tablets are an important tool in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is crucial to consult with a healthcare professional who can provide personalized guidance, monitor your progress, and adjust the treatment plan as necessary.

Please note that this description is for informational purposes only and should not replace professional medical advice. Always consult with a healthcare provider for accurate information and guidance regarding the use of Femara or any other medication.